Therefore, inactivation of insulin/PPARγ pathway in epididymal fat tissue by aliskiren may reduce fat mass and adipocyte hypertrophy, thereby contributing to a decrease in body weight and insulin resistance. This evidence concerns the gene PPARG and Insulin resistance.